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Abstract
The use of goal-directed therapy as part of an
enhanced recovery programme is well established in
terms of management of the modern high-risk
surgical patient in order to reduce both morbidity and
mortality. The mechanisms behind this improvement
are debated, but a reduction in the development of
post-operative complications including acute kidney
injury may be relevant. A recent study examining this
relationship has been reported and is discussed here.
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Since the initial observation by Shoemaker that post-
operative mortality in high-risk surgical patients could
be reduced through optimising oxygen delivery, hence
limiting the ‘oxygen debt’, much research has focussed
on this approach [1–4]. This has evolved to the concept
of goal-directed fluid therapy with optimisation of flow-
related haemodynamic variables rather than aiming for a
fixed value. Such an approach, together with initiatives
such as enhanced recovery, has been shown to improve
outcomes in patients undergoing major abdominal surgery
[5, 6]. However, major non-cardiac surgery still remains
associated with significant post-operative complications
which correlate with survival. Of these, the development
of acute kidney injury (AKI) is independently associated
with both short-term and long-term complications [7, 8].
A recent systematic review examined the incidence and
associations of AKI after major abdominal surgery and
demonstrated that the pooled incidence of AKI was
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13.4 %, with length of stay and non-renal post-operative
complications increased in those developing AKI [9]. In
studies reporting short-term mortality, the relative risk of
death in the presence of post-operative AKI was 12.6-fold.
It follows that the development of strategies to reduce
post-operative AKI may translate into improved outcomes,
which provides the basis of the study performed by Schmid
and co-workers in this issue of the journal [1]. This single-
centre, randomized controlled study examined whether the
use of an algorithm-guided goal-directed haemodynamic
therapy (GDT) using transpulmonary thermodilution could
improve renal outcomes compared to standard practice
within their institution. End-points included post-operative
complications, 1-year mortality and, as the primary end-
point, change in measured serum creatinine. One hundred
and ninety three patients were randomized, with 92
assigned to the GDT group and 88 to the control group; 13
were excluded from analysis. Transpulmonary thermodilu-
tion measurements were carried out every 30 min during
anaesthesia with global end-diastolic index (GEDI), mean
arterial pressure (MAP), and cardiac index (CI) used to as-
sess whether the algorithm objectives were met. Where a
fluid bolus was required, 500 ml hydroxyethyl starch (HES;
130/0.4 to a maximum dose of 50 ml/kg bodyweight
per day) or balanced crystalloid were used over a 15-min
period. Norepinephrine was used as a vasopressor, and do-
butamine as an inotrope. In the control group, only inva-
sive blood pressure monitoring was applied but a second
anaesthetist performed transpulmonary thermodilution
after induction and then every 30 min as in the interven-
tion arm. The attending physician was blinded to the data.
Similarly, the results were blinded during the post-
operative period in the intensive care unit (ICU).
So, what did the results show? Firstly there was no sig-
nificant difference in post-operative delta creatinine. Also,
there was no difference in post-operative complications,
hospital mortality, or 1-year mortality between the groups.
At first glance one may assume this is yet another nail in
the goal-directed therapy coffin, but perhaps this is not
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the case. A novel aspect of this study is the fact that
haemodynamic parameters were measured in both groups
and, interestingly, achievement of haemodynamic goals
was not lower in the control group. In fact >80 % of the
control group met the target values. Therefore, the algo-
rithm added little above and beyond standard care, in
keeping with some of the recent studies on the use of
goal-directed therapy in septic shock [10], or following
upper gastro-intestinal surgery such as in the OPTIMISE
study, where additionally there was minimal difference
between total fluid volume infusion between groups
[4]. Subsequent multivariate regression analysis of the
work by Schmid et al. identified intra-operative hypotension
(MAP <70 mmHg) and post-operative hypovolaemia
(GEDI <640 ml/m2) as risk factors for post-operative renal
impairment, as was the use of HES. Whilst there was no
difference between groups in the volume infused or nor-
adrenalin rates, the peri-operative use of dobutamine was
significantly higher in the intervention group. There is evi-
dence that dobutamine-induced vasodilatation can worsen
renal perfusion [11], and one may therefore question the
choice of inotrope used.
Unsurprisingly there was no effect on renal outcomes
with the use of the algorithm, although renal impairment
was found in over 50 % of both groups when defining
AKI by the Risk Injury Failure Loss Endstage (RIFLE) or
Kidney Disease Improving Global Outcomes (KDIGO)
criteria. If serum creatinine alone were used for AKI
determination, the incidence fell to 27 % and 24 %, re-
spectively. This in itself raises the issue as to how
post-operative AKI be defined. A recent retrospective
analysis of electronic health records from over 30,000
patients confirmed that not only does mortality increase
with increasing AKI severity but that when both serum
creatinine and urine output criteria are fulfilled in-hospital
mortality rises above 50 % [12]. Interestingly, surgical
admissions were far more likely to have AKI diagnosed on
urine output alone, with duration of AKI shorter when
only urinary criteria were applied which may reflect
physiological oliguria rather than functional damage in
this select group.
Does this mean that goal-directed therapy offers no
advantage in terms of reducing AKI? Obviously no such
conclusion can be drawn from this study given the lack
of differences between the two groups. There is clear evi-
dence that haemodynamic management remains important
to prevent AKI. The study by Schmid et al. and other
studies demonstrated that intra-operative hypotension
(MAP <55 mmHg) is an independent risk factor for
subsequent AKI [1, 13]. Moreover, studies in critically
ill patients with early AKI demonstrated that a higher
oxygen delivery and MAP were independently associated
with a lower risk of progression in terms of AKI, implying
a pivotal role of oxygen delivery and utilisation [14].
Clearly the use of injudicious volume therapy in whatever
clinical arena is unwise as supported by a considerable
body of evidence [15].
The trial by Schmid et al. demonstrates that, even in
the absence of specific haemodynamic optimisation, overall
care of the high-risk surgical patient seems to have im-
proved. Perhaps the future role of GDT is in the prevention
of volume depletion or overload. This might be facilitated
by the development of a volume therapeutic index, a pro-
posed next target in the field of critical care nephrology.
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